Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2026-02-26 @ 5:10 PM
Study NCT ID:
NCT01802333
Status:
COMPLETED
Last Update Posted:
2018-12-19
First Post:
2013-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02-12
Start Date Type:
None
Primary Completion Date:
2017-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-15
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-27
First Submit QC Date:
None
Study First Post Date:
2013-03-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-21
Results First Submit QC Date:
None
Results First Post Date:
2018-12-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-28
Last Update Post Date:
2018-12-19
Last Update Post Date Type:
ACTUAL